Evidence map›Paper›PMID 40802618›Full record

ArticlePloS one2025

Do organisms need an impact factor? Citations of key biological resources including model organisms reveal usage patterns and impact.

Agata Piekniewska, Martijn Roelandse, Kevin C Kent Lloyd, Ian Korf, Stephen Randal Voss, Giovanni de Castro, Diogo M Magnani, Zoltan Varga, Christina James-Zorn, Marko Horb and 2 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Agata PiekniewskaSciCrunch Inc., San Diego, California, United States of America.
Martijn RoelandseSciCrunch Inc., San Diego, California, United States of America.
Kevin C Kent LloydDepartment of Surgery, School of Medicine, Mouse Biology Program, Comprehensive Cancer Center, University of California Davis, Davis, California, United States of America.ORCID https://orcid.org/0000-0002-5318-4144
Ian KorfDepartment of Molecular and Cellular Biology, UC Davis Genome Center, University of California Davis, Davis, California, United States of America.
Stephen Randal VossAmbystoma Genetic Stock Center, Spinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, Kentucky, United States of America.
Giovanni de CastroDepartment of Medicine, UMass Chan Medical School, Worcester, Massachusetts, United States of America.ORCID https://orcid.org/0000-0002-2981-3860
Diogo M MagnaniDepartment of Medicine, UMass Chan Medical School, Worcester, Massachusetts, United States of America.ORCID https://orcid.org/0000-0002-1773-2406
Zoltan VargaZebrafish International Resource Center, Institute of Neuroscience, University of Oregon, Eugene, Oregon, United States of America.
Christina James-ZornDivision of Developmental Biology, Cincinnati Children's Research Foundation, Cincinnati, Ohio, United States of America.
Marko HorbNational Xenopus Resource, Eugene Bell Center for Regenerative Biology and Tissue Engineering, Marine Biological Laboratory, Falmouth, Massachusetts, United States of America.ORCID https://orcid.org/0000-0002-5067-0518
Jeffery S GretheDepartment of Neuroscience, School of Medicine, University of California at San Diego, San Diego, California, United States of America.
Anita BandrowskiSciCrunch Inc., San Diego, California, United States of America.ORCID https://orcid.org/0000-0002-5497-0243

Funding

NIDDK Network Coordinating UnitU24DK097771 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Shuibing Chen, Jeffrey S. Grethe · 2013 to 2026
$20.9M
Nonhuman Primate Reagent ResourceU24AI126683 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Diogo Magnani · 2016 to 2026
$20.1M
Ambystoma Genetic Stock Center - Revision to Include Curation and Informatics ComponentP40OD019794 · OD · UNIVERSITY OF KENTUCKY · PI Stephen Randal Voss · 2015 to 2026
$6.3M
Resource CoreP40OD028116 · OD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Diogo Magnani · 2020 to 2026
$5.9M
From RRID to Resource Watch: A Knowledgebase of Biomedical Research ResourcesR24GM144308 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Anita ELZBIETA Bandrowski, Jeffrey S. Grethe · 2022 to 2026
$2.9M
NIAID NIH HHS U24 AI126683NIDDK NIH HHS U24 DK097771NIGMS NIH HHS R24 GM144308NIH HHS P40 OD019794NIH HHS P40 OD028116
6 · The paper itself

Abstract

Research resources like transgenic animals and antibodies are the workhorses of biomedicine, enabling investigators to relatively easily study specific disease conditions. As key biological resources, transgenic animals and antibodies are often validated, maintained, and distributed from university-based stock centers. As these centers heavily rely on grant funding, it is critical that they are cited by investigators so that usage can be tracked. However, unlike systems for tracking the impact of papers, the conventions and systems for tracking key resource usage and impact lag. Previous studies have shown that about 50% of the resources are not findable, making the studies they support irreproducible, but also makes tracking resources difficult. The RRID (Research Resource Identifiers) project is filling this gap by working with journals and resource providers to improve citation practices and to track the usage of these key resources. Here, we reviewed 10 years of citation practices for five university based stock centers, characterizing each reference into two broad categories: findable (authors could use the RRID, stock number, or full name) and not findable (authors could use a nickname or a common name that is not unique to the resource). The data revealed that when stock centers asked their communities to cite resources by RRID, in addition to helping stock centers more easily track resource usage by increasing the number of RRID papers, authors shifted from citing resources predominantly by nickname (~50% of the time) to citing them by one of the findable categories (~85%) in a matter of several years. In the case of one stock center, the MMRRC, the improvement in findability is also associated with improvements in the adherence to NIH rigor criteria, as determined by a significant increase in the Rigor and Transparency Index for studies using MMRRC mice. From these data, it was not possible to determine whether outreach to authors or changes to stock center websites drove better citation practices, but findability of research resources and rigor adherence were improved.

Indexed as

Biomedical ResearchJournal Impact FactorAnimalsAnimals, Genetically ModifiedHumans

Identifiers

PMID40802618
PMCPMC12349098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.